A Potential Bidding War for GMS and Torrid’s Stock Price Crashes – The Special Situations Report Episode #25

Episode Summary

Executive Summary: Episode 25 reviews a dense week in event-driven markets: a possible bidding war for GMS, strategic options at Ambarella, Shell’s quick denial of BP rumors, Mars’ Kellanova deal getting U.S. antitrust clearance but facing EU scrutiny, and several completed or newly announced transactions. The hosts also highlight unconventional financing and governance moves, including Warner Bros. Discovery’s bondholder covenant tactic, Royvant’s buyback, Torrid’s distressed secondary, and multiple CEO changes across tech, retail, and REITs.

Main Topics: Potential bidding war for GMS (Priority: 5/5): Brad Jacobs’ QXO bid for GMS at about $95.20/share prompted speculation that Home Depot may also bid, creating an early-stage contest in building products. The hosts note QXO’s roll-up strategy and possible regulatory scrutiny as the platform expands. M&A regulatory landscape (Priority: 5/5): The discussion contrasts U.S. regulators’ apparent openness to remedies with the European Commission’s increasing willingness to challenge deals, especially in the Mars-Kellanova transaction. The hosts suggest this year’s antitrust risk is shifting geography. Completed and pending biotech/tech deals (Priority: 4/5): Ambarella is exploring a sale, Regulus closed to Novartis with a CVR structure and insider buying, Sage Therapeutics agreed to be acquired by Supernus with milestone-based CVRs, and Cantaloupe is being bought by 365 Retail Markets. Large-cap speculation and rumor control (Priority: 4/5): Shell’s denial of BP acquisition rumors underscored how quickly a speculative mega-deal can be shut down, with UK regulatory constraints making a near-term bid impossible under the statement’s terms. Spin-offs and capital structure engineering (Priority: 4/5): Warner Bros. Discovery’s planned split used a non-boycott covenant that weakened bondholder coordination, while Ralliant’s July 1 spin-off from Fortive represents another major separation in industrial tech. Buybacks, financing, and shareholder exits (Priority: 4/5): Royvant announced a $500 million buyback backed by net cash, while Torrid’s $20 million repurchase from Sycamore was paired with a dilutive secondary that hammered the stock. MakeMyTrip also repurchased Trip.com’s stake amid geopolitical tensions. Management changes across sectors (Priority: 3/5): Asana named a new CEO, Fastly promoted internally to CEO, Yum Brands advanced its CEO succession, FrontView REIT abruptly terminated its co-CEO/CFO, and Postal Realty’s CFO departed for a private firm.

Key Arguments: QXO’s bid for GMS could trigger a bidding war if Home Depot’s reported interest becomes an actual offer, but the deal remains early-stage and regulatory issues may intensify as QXO’s roll-up grows. The market’s reaction suggests real optionality in GMS: the stock briefly traded above $100 on takeover news, then settled near the high-90s once excitement cooled. Ambarella may be appealing despite weak long-term stock performance because it has automotive AI exposure, positive free cash flow, and net cash, though profitability is depressed by stock-based compensation. Shell’s BP rumor denial was unusually forceful and effectively removes the possibility of a near-term large BP bid under UK takeover rules. The Mars-Kellanova spread stayed wide even after FTC approval because the European Commission opened an in-depth review, showing that Europe may now be the main antitrust bottleneck in some large deals. Regulus’ insider buying after announcement was notable because the president/breeds R&D leader bought above the cash offer, implying confidence in the CVR payout. Warner Bros. Discovery’s non-boycott covenant is an innovative and potentially controversial way to secure bondholder consent by limiting collective resistance. Royvant’s buyback is credible because management has already executed prior repurchases and the company holds substantial net cash. Torrid’s situation is adverse because the company is repurchasing shares from private equity while simultaneously issuing a discounted secondary that provides no proceeds to the issuer, worsening its capital position. MakeMyTrip’s repurchase of Trip.com shares functions partly as a strategic geopolitical de-risking, reducing Chinese ownership and board influence amid data-security concerns. New CEO appointments at Asana, Fastly, and Yum Brands are framed as potential catalysts, but internal promotions at troubled tech firms may not be enough to reverse operating weakness.

Data Points: GMS bid price: $95.20 per share - QXO’s offer for GMS GMS bid value: about $5 billion - Value of Brad Jacobs/QXO offer GMS premium: 27% - Premium to GMS 60-day average trading price GMS recent trading range: over $100 then about $97 per share - Stock reaction after takeover news Ambarella five-year return: up about 51% - Long-term stock performance mentioned during strategic review discussion Ambarella ten-year return: down about one-third - Long-term stock performance mentioned during strategic review discussion Mars-Kellanova deal value: $36 billion - All-cash acquisition announced in August of the prior year Mars-Kellanova spread: 5% to 7% - Deal spread still wide after FTC early termination European Commission review deadline: October 31, 2025 - Deadline to decide on Mars-Kellanova Regulus deal cash consideration: $7 per share - Novartis acquisition structure Regulus CVR value: up to $7 per share - Contingent value right tied to FDA approval of ferribersine Regulus closing time: 56 days - Time from announcement to completion Sage Therapeutics deal value: $561 million - Supernus acquisition of Sage Therapeutics Sage cash price: $8.50 per share - Per-share acquisition price Sage premium: 26.87% - Premium to last close Sage CVR value: up to $3.50 per share - Potential additional payout tied to sales milestones Cantaloupe deal value: $848 million - Acquisition by 365 Retail Markets Cantaloupe cash price: $11.20 per share - Per-share purchase price Cantaloupe premium: 17.89% - Premium to last close Spartan Nash deal value: $1.77 billion - Acquisition by CNS Wholesale Grocers Spartan Nash cash price: $26.90 per share - Per-share acquisition price Spartan Nash premium: 52% - Premium to last closing price Spartan Nash spread: 1.4% - Market-implied spread suggesting high confidence in closing Warner Bros. Discovery debt load: $38 billion - Debt to be largely absorbed by the parent in the spin-off structure Ralliant revenue: $2.2 billion - 2024 revenues of the Fortive precision technologies division Ralliant footprint: over 90 countries - Global operating scale before July 1 spin-off Royvant market cap: $7.74 billion - Size of the holding company before buyback announcement Royvant net cash: $4.8 billion - Balance sheet cash position supporting buyback Royvant buyback: $500 million - New repurchase authorization Royvant buyback size as % of market cap: 6.5% - At announcement Prior Royvant buyback: $1.5 billion - Earlier authorization announced last year Royvant shares repurchased previously: 16% of shares outstanding - Repurchased over the last five quarters Torrid buyback: $20 million - Repurchase from Sycamore Partners rather than public market Torrid secondary price: $3.50 per share - Pricing of the secondary offering Torrid discount: 31% - Discount to the prior $5.10 trading level Torrid stock drop: nearly 38% in a single day - Reaction to discounted secondary and insider selling Torrid stock decline since IPO: down over 87% - Long-term performance since public listing Torrid additional weekly drop: 40% - Week-over-week decline around the offering news Torrid debt: almost $450 million - Debt against a market cap of $325.72 million Torrid market cap: $325.72 million - Used to illustrate leverage burden MakeMyTrip repurchase: $3 billion - Repurchase of Class B shares from Trip.com Trip.com stake after repurchase: below 20% - Ownership reduced after transaction Asana valuation comparison: 4x trailing sales vs Monday.com at 15x - Hosts’ reason for optimism on new management Fastly stock performance: down 91% over five years - Context for new CEO appointment FrontView REIT dividend: 3.47% - Mentioned during discussion of the abrupt executive termination

Pivotal Quotes: "In some sense, QXO is attempting to build a roll-up of roll-ups." — Asif Surya: Commentary on Brad Jacobs’ acquisition strategy and the GMS bid "The wording of the statement was such that under UK regulations, Shell cannot make a big deal. For BP, or at least for over 30% of BP's shares outstanding." — Damuna Suria: Explaining why Shell’s BP denial effectively blocks a near-term offer "The introduction of this non-boycott covenant is something that Warner Brothers discovery is pioneering in the world of finance." — Asif Surya: Discussion of the bondholder consent mechanics in the WBD spin-off

Implications: The episode suggests 2025 event-driven markets are being shaped by antitrust geography, aggressive roll-up strategies, creative capital-structure tactics, and governance shifts. Investors should watch regulatory timelines, CVRs, and management changes for catalysts and risks.